Lakefront Biotherapeutics N.V. (LKFT) Stock Analysis

What Lakefront Biotherapeutics N.V. does

Lakefront Biotherapeutics NV, formerly Galapagos NV, is a biotechnology company that focuses on transforming patient outcomes through scientific innovation. It is dedicated to building a pipeline of medicines for patients with serious diseases in therapeutic areas of unmet need, prioritizing oncology and immunology & inflammation programs. The company's clinical-stage portfolio is anchored by potential first-in-class treatments for autoimmune diseases.

Key metrics

ETFs linked to LKFT

Broad-market and Healthcare sector ETFs an investor holding Lakefront Biotherapeutics N.V. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how LKFT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Lakefront Biotherapeutics N.V.?

Lakefront Biotherapeutics N.V. trades under the ticker LKFT on NASDAQ.

Which exchange is LKFT listed on?

LKFT is listed on NASDAQ.

What sector does Lakefront Biotherapeutics N.V. operate in?

Lakefront Biotherapeutics N.V. is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze LKFT in a portfolio?

PortView shows LKFT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.